Number of shares and voting rights as at 31 January 2016


Article L.233-8-II of Commercial Law (Code de commerce) and

Article 223-16 of the General Regulation of the French Financial Markets Authority

(AMF – Autorité des Marchés Financiers)





31.01.2016

 






Total number of outstanding shares forming the capital

- 9,238,850 ordinary shares under ISIN FR0000054694

- 2,690 shares issued from stock-options under ISIN FR0000054694
9,241,540


Number of shares with double voting rights
2,099,889


Total number of gross voting rights
11,341,429


Number of shares without voting rights

- 3,918 bearer shares in the frame of the liquidity contract
- 3,918


Total number of exercisable voting rights*
11,337,511


*Exercisable voting rights = total number of voting rights – number of shares without voting rights






You can receive all financial information of Naturex free of charge by signing up at: www.naturex.com






Financial schedule





Results – FY 2015
30 March 2016


Upcoming events





SFAF Analysts Meeting

General Meeting
31 March 2016

21 June 2016




Naturex has been listed since October 1996 on Euronext in Paris, Segment B


Total number of shares comprising the share capital: 9,241,540 (Janvier 2016)

ISIN FR0000054694


Naturex is a component of the CACT, Enternext CAC PEA-PME 150, CAC Small & Mid, CAC Small, Gaïa Index.

Naturex is eligible for the "long only" Deferred Settlement Service (SRD) and French equity plans (PEA and PEA-PME).

Naturex established a Sponsored Level 1 American Depositary Receipt (ADR) program in the United States. Under this facility, Naturex's ADRs are traded over-the-counter in the United States under the symbol NTUXY.


TICKER: NRX - Reuters: NATU.PA - Bloomberg: NRX:FP - DR SYMBOL: NTUXY




About Naturex


Naturex is the global leader in speciality plant-based natural ingredients. The Group is organised around three strategic markets (Food & Beverage, Nutrition & Health and Personal Care) and produces and markets speciality plant-based ingredients for the food, nutraceutical, pharmaceutical and cosmetic industries.


Naturex's head office is based in Avignon. The company employs 1,500 people with 8 sourcing offices located throughout the world and high-performance manufacturing operations across 15 sites in Europe, Morocco, the United States, Brazil, Australia and India. It also has a global commercial presence through a dedicated network of sales offices in more than 20 countries.

 





Contacts

 
 


Carole Alexandre

Head of Investor Relations

Tel.: +33 (0)4 90 23 78 28

c.alexandre@naturex.com
Anne Catherine Bonjour

Actus Finance Press Relations

Tel.: +33 (0)1 53 67 36 93

acbonjour@actus.fr

Information réglementée
Information relative au nombre total de droits de vote et d'actions composant le capital :

-
Full and original press release in PDF:


http://www.actusnews.com/documents_communiques/ACTUS-0-43098-2016.02.11-Nb-of-shares-and-voting-rights_January-2016.pdf

© Copyright Actusnews Wire

Recevez gratuitement par email les prochains communiqués de la société en vous inscrivant sur www.actusnews.com

Receive by email the next press releases of the company by registering on www.actusnews.com, it's free



Quelle: Actusnews